Chinese Fine Chemicals Manufacturer Huadao Biopharma Closes $14M Series B Round

Chinese fine chemicals manufacturer Huadao Biopharma announced last week the completion of a series B round of financing worth RMB100 million (US$14.18 million) led by Shenzhen-listed chemicals developer NKY Medical Holdings.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets